Chemical and structural features influencing the biological activity of curcumin

Current Pharmaceutical Design

Volumn 19, Issue 11, 2013, Pages 2093-2100

  Priyadarsini, K Indira ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Covalent interactions; Curcumin; Hydrogen bonding; Keto enol tautomerism; O methoxyphenol

Indexed keywords

CURCUMIN; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; COVALENT BOND; DRUG STRUCTURE; HYDROGEN BOND; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 84875391491     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161213805289228     Document Type: Article

References (105)

1. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol 1976; 25: 1811-1812.
2. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003; 23: 363-398.
3. Sharma RA, Gescher AJ, Steward WP. Curcumin the story so far. Eur J Cancer 2005; 41: 1955-196.
4. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharmac Rev 2007; 4: 807-818.
5. Wilken R, Veena SM, Wang MB, Srivatsan ES. Curcumin: A review of anticancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 2011; 10: 1-19.
6. Aggarwal BB, Sundaram C, Malini N, Ichikawa H. Curcumin: The Indian solid gold. Adv Exp Med Biol 2007; 595: 243-305.
7. Anand P, Thomas SG, Kunnumakkara AB, et al. Antioxidant, antiinflammatory, anticancer, anticarcinogenic, antidiabetic and neuroprotective effects of curcumin analogues (Congeners) made by man and mother nature. Biochem Pharmacol (Review) 2008; 76: 1590-1611.
8. Hatcher H, Planapl P, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cellular and Molecular Life Science 2008; 65: 1631-1652.
9. Priyadarsini KI. Photophysics, Photochemistry and Photobiology of Curcumin: Studies from organic solutions, bio-mimetics and living cells. J Photochem Photobiol C: Chemistry Reviews, 2009; 10: 81-96.
10. Mancuso C, Barone E. Curcumin in clinical practice: myth or reality? Trends in Pharmacological Science 2009; 30: 333-334.
11. Burgos-Moron E, Calderon-Montano JM, Salvador J, Robes A Lopez-Lazaro. The dark side of curcumin. Int J Cancer 2010; 126: 1771-1775.
12. Tonnesen HH, Karlsen J, Mostad A. structural studies of curcuminoids I. The crystal structure of curcumin. Acta Chemica Scabdinavica B 1982; 32: 475-479.
13. Parimita SP, Ramshankar YV, Suresh S, Guru Row TN. Redetermination of curcumin: (1E, 4Z,6E-5-hydroxy-3-methoxy-phenylhepta- 1,4,6-triene-3-one). Acta Crystal. 2007; E63: o860-o862.
14. Emsley J, The composition, structure and hydrogen bonding of the β-diketones, in: Structure and Bonding, M. J. Clarke, J. B. Goodenough, J. A. Ibers, C. K. Jorgnesen et al., Eds, Springer-Verlag, 1984, pp 148-191
15. Wright JS. Predicting the antioxidant activity of curcumin and curcuminoids. J Mol Stru (Theochem) 2002; 591: 207-217.
16. Kolev TM, Velcheva EA, Stamboliyska BA, Spiteller M. DFT and Experimental studies of the structure and vibrational spectra of curcumin. Int J Quant Chem 2005; 102: 1069-1079.
17. Shen L, Ji HF. Theoretical study on physicochemical properties of curcumin. Spectrochim. Acta -Part A. 2007; 67: 619-623.
18. Benassi R, ferrari E, Lazzari S, Spagnolo F, Saladini M. Theoretical study on curcumin: A comparison of calculated spectroscopic properties with NMR, UV-Vis and IR experimental data. J Mole Structure 2008; 892: 168-176.
19. Balasubramanian K. Molecular orbital basis for yellow curry spice curcumin: prevention of Alzheimer's disease. J Agric Food Chem 2006; 54: 3512-3520.
20. Payton F, Sandusky P, Alworth WL. NMR study of the solution structure of curcumin. J Nat Products 2007; 143-146.
21. Tonnesen HH, Karlsen J. Studies on curcumin and curcuminoids VI. Kinetics of curcumin degradation in aqueous solution. Z. fur Lebensmittel-Untersuchung und -Forschung 1985; 180: 402-404.
22. Dietze F, Arrieta AF, Zimmer U. pKa stability constants and UV/VIS spectral behaviour of selected curcumin analogues. Pharmazie 1997; 52: 302-306.
23. Borsari M, Ferrari E, Grandi R, Saladini M. Curcuminoids as potential new iron-chemlating agents: spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability. Inorg Chim Acta 2002; 328: 61-68.
24. Murakami Y, Ishi H, Takada N, Tanaka S, Machino M, Ito S,Fujisawa S. Comparative anti-inflammatory activities of curcumin and tetrahydrocurcumin based on the phenolic-OH bond dissociation enthalpy, ionization potential and quantum chemical descriptor. Anticancer Res 2008; 28: 699-707.
25. Halliwell B, Gutteridge J. Free radicals in biology and medicine. 4th ed. Oxford University Press: London 2007.
26. Priyadarsini KI, Radiation Chemistry Applied to Antioxidant Research, 2010, in Recent Trends in Radiation Chemistry Eds.J. F. Wishart and B. S. M. Rao, World Scientific Publishers, NJ, USA, 563-596.
27. Gorman AA, Hamblett, VS, Srinivasan VS, Wood PD. Curcumin derived transients: A pulsed laser and pulseradiolysis study. Photochem Photobiol 1994; 59: 389-398.
28. Priyadarsini KI. Free radical reactions of curcumin in model membranes Free Radic Biol Med 1997; 23: 838-84.
29. Sreejayan, Rao MNA, Nitric oxide scaveneging by curcuminoids. J. pharm. Pharmacol 1997; 49: 105-107.
30. Venkatesan P, Rao MNA. Structure-activity relationship for the inhibition of lipid peroxidation and scavenging of free radical by synthetic symmetrical curcumin analogues. J Pharm Pharmacol 2000; 52: 123-128.
31. Jovanovic SV, Steenken S, Borne CW, Simic MG. H-atom transfer is a preferred antioxidant mechanism of curcumin. J Am Chem Soc 1999; 121: 9677-9681.
32. Jovanovic, SV, Boone CW, Steenken, S, Trinoga M, Kaskey RB. How curcumin works preferentially with water soluble antioxidants. J Amer Chem Soc 2001; 123: 3064-3068.
33. Barclay LRC, Vinqvist MR, Mukai K et al., On the antioxidant mechanism of curcumin: classical methods are needed to determine antioxidant mechanism and activity. Org Lett 2000; 2: 2841-2843.
34. Priyadarsini KI, Maity DK, Naik GH et al. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic Biol Med 2003; 35: 475-484.
35. Sun YM, Zhang HY, Chen DZ, Liu CB, Theoretical Elucidation on the Antioxidant Mechanism of Curcumin: A DFT Study. Org Lett, 2002; 4: 2909-2911.
36. Singh U, Barik A, Singh BG, Priyadarsini KI. Reactions of reactive oxygen species (ROS) with curcumin analogues: Structure-activity relationship. Free Radic Res 2011; 45: 317-325.
37. Litwinienko G, Ingold KU. Abnormal solvent effects on hydrogen atom abstraction 2. Resolution of the curcumin antioxidant controversy. The role of sequential proton loss electron transfer. J Org Chem 2004; 69: 5888-5896.
38. Obara K, Mizukami W, Tokunaga A, Nagaoka SI, Uno H, Mukai K. Kinetic study of the mechanism of free radical scavenging action in curcumin: Effects of solvent and pH. Bull Chem Soc Jpn 2005; 98: 615-621.
39. Gupta S, Prasad S, Ji HK et al., Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep 2011; 28: 1937-1955.
40. Gupta KK, Bharne SS, Rathinasamy K, Naik NR, Panda D. Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding. FEBS Journal, 2006; 273: 5320-5332.
41. Rai D, Singh JK, Roy N, Panda D. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J, 2008; 410; 147-155.
42. Liu Y, Yang Z, Du J, et al. Interaction of curcumin with intravenous immunoglobulin: A fluorescence quenching and Fourier transformation infrared spectroscopy study. Immunobiol 2008; 213: 651-661.
43. Zsila F, Bikadi Z, Simonyi M, Induced circular dichroism speactra reveal binding of curcumin human alpha-acid glycoprotein. Bio-org Med Chem 2004; 12: 3239-3245.
44. Zsila F, Bikadi Z, Simonyi M. Molecular basis of cotton effects induced by the binding of curcumin to albumin. Tetrahedron Asym 2003; 14: 2433-2444.
45. Mandeville JS, Froehlich E, Tajmir-Riahi HA. Study of curcumin and genistein intearctaion with human serum albumin. J Pharmac Biomed Anal 2009; 49: 468-474.
46. Barik A, Priyadarsini KI, Mohan H. Photophysical studies on binding of curcumin to bovine serum albumin. Photochem Photobiol 2003; 77: 597-603.
47. Barik A, Mishra B, Kunwar A, Priyadarsini KI. Interaction of curcumin with human serum albumin: Thermodynamic properties, fluorescence energy transfer and denaturation effects. Chem Phys Letters 2007; 436: 239-243.
48. Mitra SP. Binding and stability of curcumin in presence of bovine serum albumin. J Surf Sci Technol 2007; 23: 91-110.
49. Sahoo BK, Ghosh KS, Dasgupta S. Investigating the binding of curcumin derivative to bovine serum albumin. Biophys Chem 2008; 132: 81-88.
50. Reddy ACP, Sudharshan E, Rao AGA, Lokesh BR. Interaction of curcumin with human serum albumin: thermodynamic, fluorescence energy transfer and denaturation effects. Lipids 1999; 34: 1025-1029.
51. Kunwar A, Barik A, Pandey R, Priyadarsini KI. Transport of liposomal and albumin loaded curcumin to living cells: An absorption and fluorescence spectroscopic study. Biochim Biophys Acta, 2006; 1760: 1513-1520.
52. Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: an overview. Ann Indian Acad Neurol 2008; 11: 13-19.
53. Yanagisawa D, Taguchi H, Yamamoto A, Shirai N, Hirao K, Tooyama I. Curcuminoid binds to amyloid β1-42 oligomer and fibril. J Alzh Disease 2011; 24: 33-42.
54. Yang F, Lim GP, Begum AN et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo. J Biol Chem 2005; 280: 5892-901.
55. Reinke AA, Gestwicki JE. Structure-activity relationships of amyloid beta aggregation inhibitors based on curcumin: influence of linker length and flexibility. Chem Biol Drug Des 2007; 70: 206-215.
56. Masuda Y, Fukuchi M, Yatagawa T, et al. Solid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid β- protein fibrils. Bioorg Med Chem 2011; 19: 5967-5974.
57. Awasthi A, Pandya U, Singhal SS et al. Curcumin-glutathione interactions and the role of human glutathione S-transferase PI-1. Chem Biol Inter 2000; 128: 19-38.
58. Lersel, ML, Ploemen JP, Struik I et al., Inhibition of glutathione Stransferase activity in human melanoma cells by αβ unsaturated carbonyl derivatives. Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid and trans-2-hexanal. Chem Biol Inter 1996; 102: 117-132.
59. Fang J., Jun L., Holmegren A. Thioredoxin reductase is irreversibly modified by curcumin: A novel molecular mechanism for its anticancer activity. J Biol Chem 2005; 280: 25284-25290.
60. Jung Y., Xu W., Kim H., Ha N., Neckers L. Curcumin-induced degradation of ErbB2: A role for the E3 ubiquitin ligase CHIP and the Michael reaction acceptor activity of curcumin. Biochim Biophys Acta Mol Cell Res, 2007: 1773: 383-390.
61. Kunwar A, Barik A, Mishra B, Rathinasamy K, Pandey R, Priyadarsini KI. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim Biophys Acta 2008; 1780: 673-679.
62. Zsila F, Bikadi Z, Simonyi M. Circular dichroism spectroscopicstudies reveal pH dependent binding of curcumin in theminor groove of natural and synthetic nucleic acids. Org Biomol Chem 2004; 2:2902-2910.
63. Bera R, Sahoo BK, Ghosh K, Dasgupta S. Studies on the interaction of isoxazolcurcumin with calf thymus DNA. Int J Biol Macromolecules 2008; 42: 14-21.
64. Sahoo BK, Ghosh KS, Bera R, Dasgupta S, Studies on the interaction of diacetylcurcumin with calf thymus-DNA. Chem Phys 2008; 351: 163-169.
65. Kunwar A, Simon E, Singh U, et al. Interaction of a curcumin analogue dimethoxycurcumin with DNA. Chem Biol Drug Design 2011; 77: 281-287.
66. Nafisi S., Adelzadeh M., Norouzi Z., Sarbolouki M.N. Curcumin binding to DNA and RNA. DNA Cell Biol 2009; 28: 201-208.
67. Began G, Sudharshan E, Udaya Sankar K, Appu Rao AG, Interaction of Curcumin with Phosphatidylcholine: A Spectrofluorometric Study. J Agric Food Chem 1999; 47: 4992-4997.
68. Sun Y, Lee CC, Hung WC, Chen FY, Lee MT, Huang HW. The bound States of amphipathic drugs in lipid Bilayers: Study of curcumin. Biophys J 2008; 95: 2318-2324.
69. Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 2005; 104: 1322-1331.
70. Mourtas S, Canovi M, Zona C, et al. Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide. Biomaterials 2011; 32: 1635-1645.
71. Barry J, Fritz M, Brender JR, Smith PES, Lee DK, Ramamoorthy A. Determining the effects of lipophilic drugs on membrane structure by solid state NMR spectroscopy: the case of the antioxidant curcumin. J Amer Chem Soc 2009; 131: 4490-4498.
72. Ingolfsson HI, Koeppe RE, Andersen OS. Curcumin is a Modulator of Bilayer Material Properties. Biochemistry, 2007; 46: 10384-10391.
73. Sharma KK, Chandra S, Basu DK. Synthesis and antiarthritic study of a new orally active diferuloyl methane (curcumin) gold complex. Inorg Chim Acta 1987; 135: 47-48.
74. Jiao Y, Wilkinson J, Pietsch EC, et al. Iron chelation in the biological activity of curcumin. Free Radic Biol Med 2006; 40: 1152-1160.
75. Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. Through metal binding curcumin protects against lead- and cadmiuminduced lipid peroxidation in rat brain homogenates and against lead-induced tissue damamge in rat brain. J Biol Inorg Chem 2004; 98: 266-275.
76. Egbyl V, Kotyzova D, Leseticky L, Bludovska M, Koutensky J. The influence of curcumin and managanes complex of curcumin on cadmium induced oxidative damamge and trace elements status in tissues of mice. J Appl Toxicol 26 (2006) 207-12.
77. Song YM, Xu JP, Dang L, Hou Q, Liu JW, Zhu ZL, Syntheses, characterisation and biological activities of rare earth metal com plexes with curcumin and 1,10-phenanthroline-5,6-dione. J Biol Inorg Chem 2009; 103: 396-400.
78. Mohammadi K, Thompson KH, Patrick BO et al. synthesis and characterisation of dual function vanadyl, gallium and indium curcumin complexes for medicinal applications. J Inorg Biochem, 2005; 99: 2217-2225.
79. Thompson KH, Bohmerle K, Polishchuk E et al., Complementary inhibition of synoviocyte, smooth muscle cell or mouse lymphoma cell proliferation by a vanadyl curcumin complex compared to curcumin alone. J Inorg Biochem 2004; 98: 2063-70.
80. John VD, Kuttan G, Krishnankutty K. Anti-tumor studies of metal chelates of synthetic curcuminoids. J Exp Clin Cancer Res 2002; 21: 219-24.
81. Vajragupta O, Boonchoong P, Watanabe H, et al. Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity. Free Radic Biol Med 2003; 35: 1632-1644.
82. Vajragupta O, Boonchoong P, Berliner LJ. Manganese complexes of curcumin nanlogues: evaluation of hydroxyl radical scavenging ability, superoxide dismutase activity and stability towards hydrolysis. Free Radic Res 2004; 38: 303-14.
83. Barik A, Mishra B, Shen L., et al Evaluation of new copper-curcumin complex as superoxide dismutase mimic and its free radical reactions Free Radic Biol Med 2005; 39: 811-822.
84. Barik A, Mishra B, Kunwar A, et al. Comparative study of copper (II)-curcumin complexes as superoxide dismutase mimics and free radical scavengers. European J Med Chem 2007; 42: 431-439.
85. Kunwar A, Narang K, Priyadarsini KI, Krishna M, Pandey R, Sainis KB. Delayed activation of PKCδ and NFκB and higher radioprotection in splenic lymphocytes by Copper (II)-curcumin (1:1) complex. J Cell Biochem 2007; 102: 1214-1224.
86. Koiram PR, Veerapur VR, Kunwar A et al. Effect of curcumin and curcumin copper complex on radiation induced changes in the antioxidant enzymes levels in the livers of Swiss albino mice. J Radiat Res 2007; 48: 241-245.
87. Lou JR, Zhang XX, Zheng J, Ding WQ. Transient metals enjhance cytotoxicity of curcumin: Potential involvement of the NF-kappaB and mTOR signaling pathways. Anticancer Res 2010; 30: 3249-55.
88. Jiang T, Wang L, Zhang S et al., Interaction of curcumin with Al(III) and its complex structures based on experiments and theoretical calculations. J Mol Struct 2011; 1004: 163-173.
89. Baum L, Ng A. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J. Alzheimers Dis 2004; 6: 367-377.
90. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Antitumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995;94:79-83.
91. Sandur SK, Pandey MK, Sung B, et al. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 2007; 28: 1765-73.
92. Kunwar A, Barik A, Sandur SK, Priyadarsini KI. Differential antioxidant/ Pro-oxidant Activity of dimethoxycurcumin, a synthetic analogue of curcumin. Free Rad Res 2011; 45: 959-965.
93. Kunwar A, Jayakumar S, Srivastava AK, Priyadarsini KI. Dimethoxycurcumin- induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction and apoptosis. Arch Toxicol 2012; 86: 603-614.
94. Patwardhan RS, Checker R, Sharma D, Kohli V, Priyadarsini KI, Sandur SK. Dimethoxycurcumin, a metabolically stable analogue of curcumin, exhibits anti-inflammatory activities in murine and human lymphocytes. Biochem Pharmacol 2011; 82: 642-657.
95. Mishra S, Kapoor N, Mubarak ali A et al. Differential apoptotic and redox regulatory activities of curcumin and its derivatives. Free Radic Biol Med 2005; 38: 1353-60.
96. Airoldi C, Zona C, Erika S, et al. Curcumin derivatives as new ligands of Aβ peptides. J Biotech 2011; 156: 317-324.
97. Weber WM, Hunsaker LA, Abcouwer SF, Deck LM, Vander Jagt DL. Anti-oxidant activities of curcumin and related enones. Bioorg Med Chem 2005; 13: 3811-20.
98. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol 1978; 43: 86-92.
99. Garcea G, Jones DJ, Singh R, et al. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 2004; 90: 1011-15.
100. Hoehle SI, Pfeiffer E, Solyom AM, Metzler M. Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agric Food Chem 2006; 54: 756-64.
101. Khopde SM, Priyadarsini KI, Guha SN, Satav JG, Venkatesan P, Rao MNA. Inhibition of radiation induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci Biotech Biochem 2000; 64: 503-509.
102. Shen L, Ji HF. The pharmacology of curcumin: Is it the degradation products? Trend Mol Med 2012; 18: 138-143.
103. Price LC, Buescher RW. Kinetics of Alkaline Degradation of the Food Pigments Curcumin and Curcuminoids. J Food Science 1997; 62: 267-269.
104. Wang YJ, Pan MH, Cheng AL, et al. Stability of curcumin in buffer solutions and characterisation of its degradation products. J Pharmac Biomed Anal 1997; 15: 1867-1876.
105. Khurana A, Ho CT. High performance liquid chromatographic analysis of curcuminoids and their photo-oxidative decomposition compounds in curcuma longa. J Liq Chromat 1988; 11: 2295-2304.